{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":310,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-06-08T22:18:30.179389+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash","slug":"commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash","published_at":"2026-03-23T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/18874087-commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/18874087-commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech we're speaking with Alan Bash, President, Carvykti, at Legend Biotech, about how Carvykti became a blockbuster, category-leading CAR T therapy for multiple myeloma. Alan talks about manufacturing and delivering an autologous cell therapy at commercial scale, Legend Biotech's partnership with Johnson & Johnson, lessons he learned at Bristol Myers Squibb, Checkmate Pharmaceuticals, and ...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech we're speaking with Alan Bash, President, Carvykt…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3057,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}